2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Otto C. M., Nishimura R. A., Bonow R. O., Carabello B. A., Erwin J. P., Gentile F., ...More

Circulation, vol.143, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 143
  • Publication Date: 2021
  • Doi Number: 10.1161/cir.0000000000000932
  • Journal Name: Circulation
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, BIOSIS, CAB Abstracts, CINAHL, EMBASE, International Pharmaceutical Abstracts, MEDLINE, Veterinary Science Database
  • Keywords: AHA Scientific Statements, anticoagulation therapy, aortic regurgitation, aortic stenosis, bicuspid aortic valve, cardiac surgery, infective endocarditis, mitral regurgitation, mitral stenosis, mitral transcatheter edge-to-edge repair, prosthetic valve, pulmonic regurgitation, pulmonic stenosis, anscatheter aortic valve replacement or implantation, tricuspid regurgitation, tricuspid stenosis, valvular heart disease, AORTIC-VALVE-REPLACEMENT, ISCHEMIC MITRAL REGURGITATION, LONG-TERM OUTCOMES, LEFT-VENTRICULAR FUNCTION, CORONARY-ARTERY-DISEASE, FUNCTIONAL TRICUSPID REGURGITATION, DIRECT ORAL ANTICOAGULANTS, INTRAOPERATIVE TRANSESOPHAGEAL ECHOCARDIOGRAPHY, STAPHYLOCOCCUS-AUREUS ENDOCARDITIS, CARDIAC RESYNCHRONIZATION THERAPY
  • Eskisehir Osmangazi University Affiliated: Yes


AIM: This executive summary of the valvular heart disease guideline provides recommendations for clinicians to diagnose and manage valvular heart disease as well as supporting documentation to encourage their use.